Takeda is to acquire TiGenix, the stem cell specialist biotech with which it has developed a gastro stem cell therapy ... Takeda's chief Christophe Weber sees buy-outs as ongoing route to growth.

Studies of intracoronary stem-cell injection after acute myocardial infarction (MI) have provided conflicting results. However, as Korff Krause from Asklepios Clinic St George, Hamburg ...

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.

recently revealed that he flew to Physical Longevity in the Bahamas to undergo treatments in his knees, hips, and shoulders ...

Stem cell therapies are a type of cell therapy in which the cells used are either stem cells (as in the case of bone marrow transplantation) or are derived from stem cells, as is this case with ...

Instead, their new cells make it when it’s needed. No more seizures. No more insulin injections. Those are the words patients have always wanted to hear. And it means stem-cell researchers are ...

The Stem Cell Banking Market value was US$ $$ billion in 2022. The Stem Cell Banking Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% during ...